Skip to main content
Medicinal KLOW

A technical drafting record of the four-peptide KLOW research blend — KPV, GHK-Cu, BPC-157 and TB-500 dimensioned as four separate components on one engineering plate, the angiogenesis-vascular axis surfaced first and the missing combination data left as a blank dimension line.

KLOW Peptide References: BPC-157, TB-500, KPV, GHK-Cu

How to use the KLOW source list

Researchers studied one KLOW drug at a time. KLOW peptide means a mix of short protein chains, but the findings still belong to separate drugs. On another page, a number in square brackets points to the same numbered study here. No study of the four-part mix appears because none was found. Use the KLOW research page to read each result and its limit.

The source list gives you each study's name and, when available, a direct journal or PubMed link so you can inspect the work before deciding how much weight the finding deserves.

  1. Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368. ↗
  2. Staresinic M, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21(6):976-983. ↗
  3. Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178. ↗
  4. Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108. ↗
  5. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987. ↗
  6. Lee E, Burgess K. Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. Altern Ther Health Med. 2025;31(5):20-24. ↗
  7. Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. 2026. ↗
  8. Hsieh MJ, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med (Berl). 2017;95(3):323-333. ↗
  9. Philp D, et al. Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development. Mech Ageing Dev. 2004;125(2):113-115. ↗
  10. Wang X, Liu B, Xu Q, Sun H, Shi M, Wang D, Guo M, Yu J, Zhao C, Feng B. GHK-Cu-liposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis. Wound Repair and Regeneration. 2017;25(2):270-278. ↗
  11. Lane TF, Iruela-Arispe ML, Johnson RS, Sage EH. SPARC is a source of copper-binding peptides that stimulate angiogenesis. Journal of Cell Biology. 1994;125(4):929-943. ↗
  12. Cerovecki T / Brcic L, et al. Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing. J Physiol Pharmacol. 2009;60(Suppl 7):191-196. ↗
  13. Research note: No controlled in-vivo or human study has tested the four-peptide KLOW blend (KPV + GHK-Cu + BPC-157 + TB-500) against monotherapy, any subset, or placebo as of the publication date of this digest.
  14. Zhang Y, et al. Tβ4-exosome-loaded hemostatic and antibacterial hydrogel to improve vascularized wound repair. Mater Today Bio. 2025. ↗
  15. Sosne G, et al. Activation of pro-resolving pathways mediate the therapeutic effects of thymosin beta-4. Front Immunol. 2024. ↗